osimertinib
Osimertinib is used to treat locally advanced or metastatic non-small-cell lung cancer. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.Reference standards of Osimertinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => 2,4-Difluoronitrobenzene (BSC)
[catalogue_number] => PA BSC 05115877
[category_ids] => ,169,
[chemical_name] =>
[weight] => 159.09
[form] => C6H3F2NO2
[cas] => 446-35-5
[pslug] => 446-35-5-2-4-difluoronitrobenzene-bsc-pabsc05115877
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
2,4-Difluoronitrobenzene (BSC)
Catalogue No.:PA BSC 05115877
Molecular Formula : C6H3F2NO2
Molecular Weight : 159.09